Literature DB >> 10665742

Bone mineral density of the lumbar spine in patients with advanced rheumatoid arthritis. Influence of functional capacity and corticosteroid use.

R Saario1, P Sonninen, T Möttönen, J Viikari, A Toivanen.   

Abstract

We investigated factors that are related to generalized osteoporosis in advanced rheumatoid arthritis (RA). In this cross-sectional study we measured trabecular bone mineral density (BMD), by quantitative computerized tomography (QCT), in the lumbar spine of 57 patients with RA, most of whom were premenopausal women. In our material, 27 out of 57 patients (47%) had BMD <-1 SD expressed as Z-score and five patients had suffered from fractures. Our study shows that a cumulative corticosteroid dose (r = -0.41, p<0.010) and functional impairment (r = -0.37, p<0.050) were negatively related to spinal BMD, while daily intake of calcium correlated positively on BMD (r = 0.37, p<0.010). Our results indicate that low BMD is common in patients with advanced RA and it is associated with long-term corticosteroid use. Thus, in clinical practice we have to consider the benefits and harms of corticosteroid treatment and preventive therapy to osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10665742     DOI: 10.1080/03009749950155355

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  8 in total

1.  The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.

Authors:  Funda Tascioglu; Omer Colak; Onur Armagan; Ozkan Alatas; Cengiz Oner
Journal:  Rheumatol Int       Date:  2005-02-02       Impact factor: 2.631

2.  Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.

Authors:  B Juhász; K Gulyás; Á Horváth; Z Pethő; H P Bhattoa; A Váncsa; É Szekanecz; C Horváth; J Kocsis; Z Horváth; K Hodosi; S Szántó; G Szűcs; Z Szekanecz
Journal:  Osteoporos Int       Date:  2016-12-10       Impact factor: 4.507

3.  Bone status in glucocorticoid-treated men and women.

Authors:  E S Leib; R Winzenrieth
Journal:  Osteoporos Int       Date:  2015-08-08       Impact factor: 4.507

4.  The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis.

Authors:  Funda Tascioglu; Cengiz Oner; Onur Armagan
Journal:  Rheumatol Int       Date:  2003-03-21       Impact factor: 2.631

5.  Long term high intensity exercise and damage of small joints in rheumatoid arthritis.

Authors:  Z de Jong; M Munneke; A H Zwinderman; H M Kroon; K H Ronday; W F Lems; B A C Dijkmans; F C Breedveld; T P M Vliet Vlieland; J M W Hazes; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

6.  Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis.

Authors:  Peter Oelzner; Antje Schwabe; Gabriele Lehmann; Thorsten Eidner; Sybille Franke; Gunter Wolf; Gert Hein
Journal:  Rheumatol Int       Date:  2008-04-30       Impact factor: 2.631

Review 7.  Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease.

Authors:  B F Ricciardi; J Paul; A Kim; L A Russell; J M Lane
Journal:  Osteoporos Int       Date:  2012-09-07       Impact factor: 4.507

8.  The effect of low-dose prednisone on bone mineral density in Peruvian rheumatoid arthritis patients.

Authors:  Cecilia P Chung; Anthony S Russell; Maria I Segami; César A Ugarte
Journal:  Rheumatol Int       Date:  2003-11-20       Impact factor: 2.631

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.